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        Introduction 
  Double-strand breaks (DSBs) pose a major threat to genomic 
integrity by promoting mutations, gene deletions, and/or chro-
mosomal translocations (  Shiloh, 2003; Kastan and Bartek, 
2004  ). These adverse effects are counteracted by genome sur-
veillance machinery that is designed to rapidly detect DSBs, 
delay cell cycle progression, initiate DNA repair, or, in case 
of excessive damage, activate the cell death program (  Zhou 
and Elledge, 2000; Nyberg et al., 2002  ;   Lukas et al., 2004b  ). 
Because the maintenance of genome integrity requires extreme 
accuracy and coordination of elaborate, often intertwined mo-
lecular pathways, cells evolved numerous means to increase 
the effi  ciency of this process. Among others, virtually every 
eukaryotic cell responds to DSBs by concentrating signaling, 
repair, and various adaptor proteins in the vicinity of DNA le-
sions (  Lukas et al., 2005  ). Although the purpose of this phe-
nomenon (cytologically manifested by the formation of nuclear 
foci enriched in various DSB regulators) is not yet fully under-
stood, several intriguing scenarios have been considered: for 
instance, DNA damage  –  induced protein accumulation may fa-
cilitate the formation of active repair holocomplexes, increase 
the availability of these enzymes at the sites of genetic lesions, 
generate a local chromatin microenvironment supportive for 
repair-associated DNA transactions, and/or amplify the DSB-
associated signaling (  Fernandez-Capetillo et al., 2004  ;   Essers 
et al., 2006  ;   Stucki and Jackson, 2006; Bartek and Lukas, 
2007 ). Thus, the local concentration of DSB regulators emerges 
as a vital tool to increase the fi  delity of the genome surveil-
lance machinery. 
  Prominent among the cellular factors that accumulate at 
DSBs is the MRE11  –  RAD50  –  Nijmegen breakage syndrome 1 
(NBS1 [MRN]) complex, an essential genome caretaker that 
regulates crucial steps of the DSB response such as DSB detec-
tion, activity of the ataxia telangiectasia mutated (ATM) 
kinase (the key upstream component of DSB signaling), cell 
cycle checkpoints (  D  ’  Amours and Jackson, 2002  ;   Petrini and 
Stracker, 2003  ;   Kobayashi et al., 2004  ;   Stracker et al., 2004  ), 
and, as the most recent advancements suggest, induction of 
apoptosis (  Difi  lippantonio et al., 2007  ;   Stracker et al., 2007  ). 
In addition, the MRN complex participates in the resection of 
  D
NA double-strand breaks (DSBs) trigger accumula-
tion of the MRE11  –  RAD50  –  Nijmegen breakage 
syndrome 1 (NBS1 [MRN]) complex, whose reten-
tion on the DSB-ﬂ   anking chromatin facilitates survival. 
Chromatin retention of MRN requires the MDC1 adaptor 
protein, but the mechanism behind the MRN  –  MDC1 inter-
action is unknown. We show that the NBS1 subunit of MRN 
interacts with the MDC1 N terminus enriched in Ser-Asp-
Thr (SDT) repeats. This interaction was constitutive and me-
diated by binding between the phosphorylated SDT repeats 
of MDC1 and the phosphate-binding forkhead-associated 
domain of NBS1. Phosphorylation of the SDT repeats by 
casein kinase 2 (CK2) was sufﬁ   cient to trigger MDC1  –
  NBS1 interaction in vitro, and MDC1 associated with CK2 
activity in cells. Inhibition of CK2 reduced SDT phosphory-
lation in vivo, and disruption of the SDT-associated phos-
phoacceptor sites prevented the retention of NBS1 at DSBs. 
Together, these data suggest that phosphorylation of the 
SDT repeats in the MDC1 N terminus functions to recruit 
NBS1 and, thereby, increases the local concentration of 
MRN at the sites of chromosomal breakage.
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Ser139 of     -H2AX (  Stucki et al., 2005  ). As a result, MDC1 is 
among the fi  rst proteins to accumulate at the DSB sites, and its 
productive assembly in this compartment is a prerequisite for 
retention of most of the known chromatin-binding DSB regu-
lators, including the MRN complex ( Stucki and Jackson, 2006 ). 
The key evidence for the causative role of MDC1 for MRN 
focus formation was provided by several independent stud-
ies, which all showed that the siRNA-mediated knockdown of 
MDC1 by RNA interference in human cells (  Goldberg et al., 
2003  ;   Stewart et al., 2003; Lukas et al., 2004a  ) or a complete 
MDC1 knockout in mouse cells (  Lou et al., 2006  ) prevented 
MRN retention at the DSB-fl  anking chromatin. Importantly, 
kinetic measurements in living cells extended these results 
by showing that the MDC1 knockdown abolished MRN re-
tention at DSBs from the earliest stages after DNA damage 
and that in the absence of MDC1, NBS1 could not concentrate 
at the DSB-fl  anking chromatin despite the fact that H2AX 
was effi  ciently phosphorylated in these compartments (  Lukas 
et al., 2004a  ). 
  At lest three additional pieces of evidence suggested that 
the retention of MRN at the DSB-fl  anking (and    -H2AX  deco-
rated) chromatin is not direct but is mediated by interaction 
with MDC1. First, peptides derived from the phosphorylated 
    -H2AX C terminus interacted with MRN only in the presence 
of MDC1 (  Lukas et al., 2004a  ). Second, MDC1 can be effi  -
ciently copurifi  ed with MRN from cell extracts (  Goldberg et al., 
2003  ;   Stewart et al., 2003; Lukas et al., 2004a  ). Importantly, 
this interaction was dependent on the phosphate-binding FHA 
domain of NBS1, suggesting that the formation of a productive 
MDC1  –  MRN complex is phosphorylation dependent (  Lukas 
et al., 2004a  ). Third, real-time imaging of protein assembly in 
live cells revealed that NBS1 accumulates at the DSB-fl  anking 
chromatin with a dynamics that is indistinguishable from that 
of MDC1 (but signifi  cantly faster than other chromatin-binding 
proteins such as 53BP1 or BRCA1), an observation that fur-
ther supported the emerging model of the intimate relationship 
between MDC1 and the MRN complex (  Lukas et al., 2004a  ; 
  Bekker-Jensen et al., 2005  ;   Mailand et al., 2007  ). 
  Although intriguing, these results left several mechanistic 
questions unanswered: most notably, it remains unclear whether 
the phosphosubstrate of the NBS1-FHA domain is indeed 
MDC1 itself or whether the MDC1  –  NBS1 interaction requires 
yet another, hitherto unrecognized (phospho)intermediate. 
Furthermore, the identity of the protein kinases and the phos-
phorylation sites that generate the recognition signal for the 
NBS1-FHA domain (and thus promote retention of MRN 
on the DSB-fl  anking chromatin) have not been determined. 
In an attempt to resolve these issues, we performed a detailed 
analysis of the MDC1  –  NBS1 interaction in vitro and in cells. 
We show that the NBS1-FHA domain binds to the N-terminal 
part of MDC1 enriched in acidic Ser-Asp-Thr (SDT) repeats. 
Furthermore, we provide evidence that the SDT repeats are 
constitutively phosphorylated, at least in part, by casein kinase 2 
(CK2). These SDT phosphorylations are functionally signifi  -
cant because they trigger productive interaction between MDC1 
and NBS1 and determine the retention of MRN at the DSB-
modifi  ed chromatin. 
DNA ends, an essential step required for an error-free DSB re-
pair by homologous recombination ( Jazayeri et al., 2006 ). Such 
diverse involvement in the DSB response is refl  ected by the 
nuclear dynamics of MRN. Most notably, recent studies re-
vealed that the distribution of NBS1 (and other MRN compo-
nents) at the DSB sites is not uniform but splits into distinct 
subcompartments (  Lukas et al., 2004a; Bekker-Jensen et al., 
2006  ). Although a fraction of MRN interacts with single-
stranded DNA formed after enzymatic DSB resection (consis-
tent with the essential role of MRN in DSB resection), the bulk 
of the DSB-associated MRN accumulates within the vast re-
gions of chromatin marked by ATM-phosphorylated histone 
H2AX (    -H2AX). It is indeed this chromatin-associated frac-
tion of MRN that cytologically manifests as the so-called ion-
izing radiation (IR)  –  induced foci. 
  The function of the chromatin-bound MRN has been sub-
jected to intensive investigation and yielded important insights. 
Thus, it was found that the forkhead-associated (FHA) domain 
of NBS1 is necessary for its retention at the DSB-fl  anking chro-
matin and that its disruption impairs IR-induced foci formation 
of the entire MRN complex (  Zhao et al., 2002; Cerosaletti and 
Concannon, 2003  ). Reconstitution experiments in human cells 
derived from the NBS patients suggested that the NBS1 N ter-
minus, where the FHA domain resides, is important for sur-
vival, optimal ATM activity, and the intra  –  S-phase checkpoint 
after IR (  Tauchi et al., 2001  ;   Zhao et al., 2002; Cerosaletti and 
Concannon, 2003, 2004  ;   Lee et al., 2003  ;   Horejsi et al., 2004  ; 
  Cerosaletti et al., 2006  ). However, because these assays were 
performed on the background of low levels of hypomorphic 
NBS1 alleles, the exact role of the chromatin-bound MRN re-
mained a matter of debate. An important breakthrough in this 
discussion has been recently provided by   Difi  lippantonio et al. 
(2005, 2007) , who generated a mouse strain in which the endog-
enous NBS1 gene was replaced by a mutant with the disrupted 
FHA domain. Remarkably, although these mice were viable, 
they displayed defects in the DNA damage  –  induced G2/M- and 
S-phase checkpoints, an increased incidence of chromosomal 
aberrations, attenuated ATM activity after low doses of IR, and 
a decreased radiation survival. Although it is possible that the 
NBS1 N terminus supports other functions than the chromatin 
tethering of MRN, these results provide the most compelling 
evidence so far that the chromatin-bound MRN contributes to 
reach the threshold of the DNA damage signaling (especially 
after a low dose of IR), thereby guarding against chromo-
somal instability. 
  Although the requirement of the NBS1-FHA domain for 
the MRN focus formation has been established, the way this 
domain communicates with the DSB-fl  anking chromatin and/or 
the associated proteins is less clear. An earlier study sug-
gested that the NBS1-FHA domain directly binds to    -H2AX 
(  Kobayashi et al., 2002  ). However, more recent results showed 
that the interaction of NBS1 with the DSBs requires MDC1, 
a large adaptor protein and an important upstream coordina-
tor of the DSB-induced chromatin response (  Goldberg et al., 
2003  ;   Stewart et al., 2003; Lukas et al., 2004a  ;   Lou et al., 
2006  ). MDC1 contains tandem BRCA1 C-terminal (BRCT) 
domains, which bind with high specifi  city to phosphorylated 215  MECHANISM OF NBS1 CHROMATIN RETENTION   •   MELANDER ET AL.
  Figure 1.       Interaction between NBS1 and MDC1 is mediated by the FHA domain of NBS1 and the ﬁ  rst 500 amino acids of MDC1.   (A) Endogenous MDC1 
and NBS1 interact both before and after DNA damage. Lysates from U2OS cells either mock or      irradiated (10 Gy for 1 h) were subjected to immuno-
precipitation with an anti-MDC1 antibody and analyzed for the presence of NBS1 by immunoblotting. A nonimmune species-matched antibody was used 
as a control. Expression levels of NBS1 in whole cell extracts (bottom) indicate an equal input in each lane. (B) A schematic structure of MDC1 and NBS1. 
The red segment indicates the N-terminal region of MDC1 (amino acids 1  –  1,100) subjected to progressive deletion and interaction analysis with NBS1. 
(C) The N-terminal region of MDC1 spanning the ﬁ  rst 500 amino acids efﬁ  ciently interacts with cellular NBS1. The indicated HA-tagged fragments of the 
MDC1 N terminus were transfected into MDC1/shRNA cells (the numbers indicate the C-terminal amino acid of each fragment). After 24 h, lysates were 
prepared, subjected to immunoprecipitation with an anti-HA antibody, and analyzed by immunoblotting with antibodies to NBS1 (top) and HA (middle). 
The input into each reaction was controlled by NBS1 immunoblotting of the whole cell extracts as in A (bottom). (D) Efﬁ  cient knockdown of endogenous 
MDC1. Lysates from U2OS cells and its derivative in which MDC1 is knocked down by stably integrated shRNA (MDC1/shRNA) were analyzed by 
immunoblotting with an MDC1-speciﬁ  c antibody (top). The NBS1 immunoblot serves as a loading control and indicates that the overall levels of NBS1 are 
not affected by the MDC1 knockdown (bottom). (E) The FHA domain of NBS1 interacts with the MDC1 N terminus. MDC1/shRNA cells were cotransfected 
with the HA-tagged MDC1 N terminus (p1100) and the following Myc-tagged variants of NBS1: WT (wild type), R28 (nonfunctional FHA domain),   Δ  C 
(C-terminal deletion without the MRE11 and ATM interaction domains), and 3A (alanine substitutions of serines 278, 343, and 397, the ATM phosphorylation 
sites). After 24 h, lysates were immunoprecipitated with an anti-HA antibody and analyzed by immunoblotting with anti-Myc (top) and anti-HA (middle) 
antibodies. The bottom panel is an immunoblot of whole cell extracts and shows the input of each of the Myc-tagged NBS1 proteins. WCE, whole cell 
extract; PST, Pro-Ser-Thr rich.     JCB • VOLUME 181 • NUMBER 2 • 2008  216
spanning the N-terminal part of MDC1 (  Fig. 1 C  ). We transiently 
expressed each of these fragments in a U2OS cell line in which the 
endogenous MDC1 was down-regulated by stably integrated short 
hairpin RNA (shRNA;   Fig. 1 D  ;   Bekker-Jensen et al., 2006  ) and 
tested their ability to interact with endogenous NBS1. The MDC1 
fragments were constructed so that they were not affected by the 
shRNA to endogenous MDC1 (see Materials and methods), and 
the robust down-regulation of MDC1 in this cell line (designated 
U2OS/shMDC1) allowed us to assess the binding effi  ciency of 
each fragment unbiased by higher-order complexes containing the 
  Results 
  The FHA domain of NBS1 interacts with 
the N-terminal part of MDC1 
  Endogenous MDC1 and NBS1 proteins effi  ciently interact both 
before and after DNA damage (  Fig. 1 A  ) and contain numerous 
structural motifs and potential targets for posttranslational modi-
fi  cations (  Fig. 1 B  ) that might be involved in this interaction. 
To elucidate the requirements for the MDC1  –  MRN interaction, 
we fi  rst constructed a series of HA-tagged fragments progressively 
  Figure 2.       The SDT-rich region within the 
MDC1 N terminus promotes MDC1  –  NBS1 
interaction.   (A) The N-terminal part of MDC1 
delineated by amino acids 218 and 455 
contains six acidophilic Ser-Thr-Asp (SDT) re-
peats. (B) A schematic depiction of the MDC1 
fragments used in C for the NBS1 binding as-
say. (C) The SDT region is necessary for and 
sufﬁ  cient to promote interaction of the MDC1 
N terminus with NBS1. MDC1/shRNA cells 
were transfected with the HA-tagged MDC1 
fragments described in B. After 24 h, lysates 
were prepared, immunoprecipitated with an 
anti-HA antibody, and analyzed by immuno-
blotting with NBS1 (top) and HA (middle) 
antibodies. The bottom panel is an immuno-
blot of whole cell extracts and shows equal in-
put of each NBS1 in each lane. WCE, whole 
cell extract.     217  MECHANISM OF NBS1 CHROMATIN RETENTION   •   MELANDER ET AL.
endogenous protein. Under these conditions, a fragment spanning 
the fi  rst 500 amino acids of MDC1 appeared to be necessary and 
suffi  cient to bind cellular NBS1 ( Fig. 1 C , lane 6), and this binding 
did not further increase after including the more C-terminal se-
quences (  Fig. 1 C  , lanes 7 and 8). Interestingly, although MDC1 
also contains an FHA domain at the very N terminus, this domain 
(either isolated or in the context of a larger fragment spanning up 
to the fi  rst 200 amino acids of MDC1) appeared to be entirely dis-
pensable for NBS1 interaction (  Fig. 1 C  , lanes 1 and 2). 
  We then performed a reciprocal analysis and tested the 
structural requirements of NBS1 to interact with the MDC1 
N terminus. To this end, we coexpressed the HA-tagged N-terminal 
fragment of MDC1 spanning the fi  rst 1,100 amino acids (p1100) 
with various Myc-tagged variants of NBS1 and assessed their inter-
action by an immunoprecipitation assay. Consistent with a pre-
vious study that measured the interaction of NBS1 mutants with 
full-length MDC1 (  Lukas et al., 2004a  ), we found that a point 
mutation within the NBS1-FHA domain (NBS1 
R28 )  completely 
uncoupled NBS1 from the MDC1 N terminus (  Fig. 1 E  , lane 2). 
In contrast, neither disruption of the NBS1 C terminus responsi-
ble for interaction with MRE11 and ATM (NBS1 
 Δ C )  nor  mutation 
of the three major phosphorylation sites targeted by the ATM ki-
nase (NBS1 
3A  ) had a measurable effect, and these mutants inter-
acted with the MDC1 fragment as effi  ciently as the wild-type 
(WT) NBS1 (  Fig. 1 E  ). Together, these data suggest that the 
MDC1 N terminus contains the necessary structural signature to 
allow recognition of MDC1 by the FHA domain of NBS1. 
  The SDT-rich region in the MDC1 
N terminus mediates interaction 
with NBS1 
  Next, we subjected the N-terminal fragment of MDC1 to a bio-
informatic analysis and searched for conserved motifs that may 
potentially mediate the interaction with NBS1. Interestingly, the 
region between amino acids 210 and 460 (that is, the part of MDC1 
identifi  ed in the previous section as necessary and suffi  cient 
to bind NBS1) contained up to six acidic SDT motifs, some of 
which are conserved among different vertebrate species (  Fig. 2 A   
and Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb
.200708210/DC1). To test whether the SDT clusters infl  uence 
the MDC1  –  NBS1 interaction, we generated another set of MDC1 
fragments either spanning different parts of the SDT-containing 
region or harboring an in-frame deletion of the entire SDT region 
(  Fig. 2 B  ). The fragment containing all six SDT repeats effi  ciently 
bound to endogenous NBS1 when expressed in the U2OS/shRNA 
cell line (  Fig. 2 C  , lane 4). Strikingly, even shorter fragments con-
taining either three N-terminal (SDT1) or four C-terminal (SDT2) 
repeats still interacted with NBS1, albeit with a lower effi  ciency 
than the full-length SDT region ( Fig. 2 C , lanes 5 and 6). Conversely, 
deletion of the entire SDT region completely abolished the ability 
of the MDC1 N terminus to bind NBS1 under these conditions 
(  Fig. 2 C  , lane 3). Together, these data indicate that the SDT 
repeats within the MDC1 N terminus might be involved in binding 
to NBS1, and we set out to further explore this possibility. 
  The SDT repeats are phosphorylated 
in vivo 
 We reasoned that if the SDT repeats mediate the MDC1 – NBS1 in-
teraction, the Ser/Thr residues within the repeats should be phos-
phorylated in vivo. To test this important prediction, we   analyzed 
phosphorylation patterns of various forms of MDC1 (  Fig. 3 A  ) 
immunopurifi  ed from U2OS cells metabolically labeled with 
[ 
32  P]orthophosphate. As expected, the tryptic phosphopeptide 
map of endogenous MDC1 revealed considerable complexity, in-
dicating that numerous phosphorylation events converge on these 
large adaptor proteins (  Fig. 3 B  ). Strikingly, the majority of the 
phosphopeptide spots observed in the endogenous protein were 
preserved in the N-terminal fragment of MDC1 (  Fig. 3 C  ), and 
some of the most prominent spots were clearly also resolved in 
the isolated SDT region (  Fig. 3 E  ). Indeed, a systematic analysis 
of various deletion fragments and/or the SDT mutants in which 
the Ser/Thr residues were substituted to Ala confi  rmed that at least 
four of the prominent SDT clusters are subjected to phosphory-
lation in vivo ( Table I ). A typical example of such an assay is pro-
vided in   Fig. 3 (F and G)  , where mutation of the second (amino 
acids 299/301) or the sixth (amino acids 453/455) SDT repeat 
eliminated the respective prominently labeled spot. Consistently, 
an N-terminal fragment of MDC1 terminating within the SDT 
region (at amino acid 400) lacked the spot corresponding to the 
sixth SDT (amino acids 453/455;   Fig. 3 D  ). In addition, assess-
ment of the spot charges after mutating single phosphoacceptor 
sites (Fig. S2 A, available at http://www.jcb.org/cgi/content/full/
jcb.200708210/DC1) and a direct phospho  –  amino acid analysis 
of the prominently labeled SDT repeats (Ser299/Thr301 and 
Ser453/Thr455, respectively; Fig. S2 B) confi  rmed that both Ser 
and Thr residues were simultaneously phosphorylated. Together 
with recent results from the large-scale phosphoproteomic pro-
jects that independently confi  rmed phosphorylation of the SDT 
clusters ( Table I ), these data show that the SDT repeats within the 
MDC1 N terminus are indeed phosphorylated in vivo and sug-
gest that the SDT-associated phosphates may serve as docking 
sites for the FHA domain of NBS1. 
  Table I.       In vivo phosphorylated SDT sites   
Site (amino acids) Identiﬁ  ed by phosphotryptic analysis  
  (this study)
Identiﬁ  ed by mass spectrometry  
  (references)
218/220       
299/301 + Olsen et al., 2006
329/331 + Beausoleil et al., 2004; Olsen et al., 2006
376/378       
402/404 + Olsen et al., 2006
453/455 + Beausoleil et al., 2004; Olsen et al., 2006JCB • VOLUME 181 • NUMBER 2 • 2008  218
dues in all six SDT repeats were changed to Ala (designated as 
12A) and subjected these fragments to phosphorylation by CK2 
in an in vitro kinase assay. Indeed, CK2 effi  ciently phosphory-
lated the WT SDT fragment in vitro (  Fig. 4 A  , lane 5), and this 
phosphorylation was inhibited by adding the CK2 inhibitor into 
the kinase reaction (  Fig. 4 A  , lane 8). Signifi  cantly, phosphory-
lation of the SDT-12A mutant was very ineffi  cient (  Fig. 4 A  , 
lane 6), suggesting that the bulk of the CK2-mediated phospho-
rylations within the MDC1 N terminus was indeed targeted to 
the SDT repeats. 
  CK2 phosphorylates the SDT repeats and 
promotes interaction between the MDC1 
N terminus and NBS1 
  To test this hypothesis, we fi  rst tried to identify the kinase that 
can phosphorylate the SDT repeats. Sequence analysis by the 
recently introduced NetworKIN approach (  Linding et al., 2007  ) 
revealed that the SDT clusters strongly resemble consensus sites 
for the acidophilic protein kinase CK2. Therefore, from   Esche-
richia coli  , we purifi  ed a GST-tagged SDT fragment (spanning 
amino acids 181  –  480) and its variant in which the Ser/Thr resi-
  Figure 3.       MDC1 N terminus is phosphorylated in vivo, and some of the prominent phosphorylation sites include the SDT clusters.   (A) A schematic diagram 
of MDC1 and the position of the fragments used to identify phosphorylation sites in vivo. (B  –  G) Examples of SDT-associated Ser/Thr phosphorylations in 
vivo. U2OS cells either untransfected (B) or transfected with the indicated HA-tagged MDC1 constructs (C  –  G) were labeled with  
32  P for 4 h. Lysates from 
labeled cells were immunoprecipitated with anti-MDC1 (B) or anti-HA (C  –  G) antibodies, and the isolated proteins were subjected to tryptic digestion. 
The resulting peptides were separated by electrophoresis followed by thin-layer chromatography and analyzed by phosphorimager. The spots indicated by 
arrows mark prominent phosphopeptides derived from Ser 
299  /Thr 
301   (thin arrows) and Ser 
453  /Thr 
455   (bold arrows). Open circles mark the loading spots, 
and numbers indicate the charge of the phosphopeptides. Dotted arrows indicate the absence of a phosphopeptide spot.     219  MECHANISM OF NBS1 CHROMATIN RETENTION   •   MELANDER ET AL.
ity to interact with an in vitro  –  translated  
35 S-labeled  NBS1. 
Effi  cient phosphorylation of the WT (but not the 12A) SDT 
fragment was confi  rmed by a marked mobility shift on the SDS 
gel (  Fig. 4 B  , bottom). Strikingly, only the CK2-phosphorylated 
but not the unmodifi  ed SDT region interacted with NBS1 in this 
  To test the impact of CK2-mediated phosphorylation 
of the MDC1 N terminus on its interaction with NBS1, we 
phosphorylated (or mock treated) the GST-tagged WT or the 
phosphorylation-defi  cient (12A) SDT fragments (using non-
radioactive ATP in the kinase reaction) and assessed their abil-
  Figure 4.       Phosphorylation of the SDT clusters by CK2 promotes MDC1  –  NBS1 interaction in vitro.   (A) CK2 phosphorylates the SDT repeats of MDC1 
in vitro. GST-MDC1 fragment spanning the entire SDT region (WT; amino acids 181  –  480) or its derivative in which all 12 potential CK2 sites were 
mutated to alanines (12A) was puriﬁ  ed from   E. coli   and subjected to an in vitro kinase assay using a recombinant CK2 and  
32  P-labeled ATP. Where 
indicated, 10   μ  M of the DMAT CK2 inhibitor (CK2i) was added to the reaction. After separation by SDS-PAGE, the gel was stained with Coomassie blue 
to validate the equal input of the GST-MDC1 fragments (bottom) and was dried and analyzed by phosphorimager (top). (B) The puriﬁ  ed SDT region of 
MDC1 interacts with NBS1 in a phosphorylation- and CK2-dependent manner. GST-MDC1 fragments (as in A) were phosphorylated or not phosphory-
lated with recombinant CK2 (using nonradioactive ATP), captured on glutathione  –  Sepharose beads, and incubated with in vitro  –  translated  
35  S-labeled 
NBS1 WT or its derivative with a point mutation within the FHA domain (R28) for 2 h. Bound complexes were resolved by SDS-PAGE. The gel was 
stained with Coomassie blue to validate equal input of the GST-MDC1 proteins (bottom), and the bound NBS1 was analyzed by phosphorimager (top). 
CB, Coomassie blue.     JCB • VOLUME 181 • NUMBER 2 • 2008  220
  The SDT repeats are required for 
MDC1  –  NBS1 interaction in vivo 
  To directly test whether the SDT repeats determine MDC1  –
  NBS1 interaction in vivo, we expressed in U2OS cells the HA-
tagged MDC1 N termini with progressively increasing mutations 
within the SDT repeats and assessed their ability to bind endog-
enous NBS1. The isolated mutations of the Ser/Thr residues 
within the second (amino acids 299/301) or the sixth (amino ac-
ids 453/455) SDT cluster had only marginal effects, and these 
mutants bound NBS1 almost as effi  ciently as the WT MDC1 
N terminus (  Fig. 7 A  , lanes 1  –  3). Strikingly, a combination of 
these mutations (designated as 4A) markedly impaired the ability 
to bind NBS1 (  Fig. 7 A  , lane 4), and mutation of the Ser/Thr resi-
dues in all six SDT clusters (12A) abolished the MDC1  –  NBS1 
interaction completely (  Fig. 7 A  , lane 5). Thus, consistent with 
the in vitro binding experiments described in   Fig. 4  , the integrity 
of the SDT repeats appears to be critical to support the inter-
action between MDC1 and NBS1 in cells. In addition, the pro-
gressive attenuation of this interaction achieved by increasing 
mutations of the SDT-associated Ser/Thr residues suggested that 
the SDT repeats (especially the dominant ones such as Ser299/
Thr301 and Ser453/Thr455) bind NBS1 in a redundant fashion. 
  The SDT repeats determine the retention 
of NBS1 at the DSB-modiﬁ  ed chromatin 
  Having obtained biochemical evidence for a link between the 
phosphorylated N terminus of MDC1 and the FHA domain 
of NBS1, we set out to investigate the functional relevance of 
these observations for chromatin retention of NBS1 at the DSB-
modifi  ed chromatin. To this end, we again used the U2OS-derived 
in vitro binding assay (  Fig. 4 B  , lane 3). Importantly, this inter-
action required the intact FHA domain of NBS1, as the R28 
mutant of NBS1 failed to bind to the MDC1 N terminus even 
though this was effi  ciently phosphorylated (  Fig. 4 B  , lane 8). 
The SDT-12A mutant did not bind to any form of NBS1 under 
these conditions (  Fig. 4 B  , lanes 4, 5, 9, and 10). 
  To explore the emerging cross talk between CK2 and the 
N terminus of MDC1, we tested the impact of CK2 inhibition on 
SDT phosphorylation in cells. Indeed, preincubation of U2OS 
cells with a CK2 inhibitor signifi  cantly reduced the overall 
incorporation of radioactive phosphate to the ectopically ex-
pressed SDT fragment (  Fig. 5 A  ). More importantly in this con-
text, the ensuing phosphopeptide analysis revealed that this was 
accompanied by an     50% reduction of phosphate incorporation 
into two prominent SDT repeats (Ser299/Thr301 and Ser453/
Ser455;   Fig. 5 B  ). Thus, CK2 can at least partially phosphorylate 
the SDT repeats in vivo. To further support this conclusion, we 
immunopurifi  ed HA-tagged MDC1 N terminus (  Fig. 6 A  ) or 
endogenous MDC1 (  Fig. 6 B  ) from cells and subjected these 
immunocomplexes to an in vitro kinase assay (without any addi-
tional substrate). In both cases, MDC1 copurifi  ed with an au-
tocatalytic kinase activity that was strongly attenuated by a 
specifi  c CK2 inhibitor (  Fig. 6, A and B  ). Interestingly, this 
MDC1-associated CK2 activity was clearly present in undam-
aged cells (  Fig. 6, A   and B; lane 1) and did not appreciably in-
crease after exposing the cells to IR ( Fig. 6 A , lane 2). Collectively, 
the data in   Figs. 4  –  6   show that CK2 can phosphorylate the SDT 
repeats and suggest that this may contribute to trigger a produc-
tive interaction between the MDC1 N terminus and the FHA do-
main of NBS1. 
  Figure 5.       Inhibition of CK2 reduces phosphorylation 
of the SDT repeats in vivo.   (A) Treatment of cells with 
a CK2 inhibitor reduces phosphate incorporation into 
the SDT-containing fragment of MDC1. U2OS cells 
were transfected with the HA-tagged fragment of MDC1 
spanning the entire SDT region (amino acids 210  –  460) 
and labeled with  
32  P for 4 h. Where indicated, 10   μ  M 
of the DMAT CK2 inhibitor (CK2i) was added to the 
culture medium for the entire labeling period. Lysates 
from labeled cells were immunoprecipitated with an 
anti-HA antibody and, after resolving the proteins on 
SDS-PAGE, were analyzed by the phosphorimager for 
the extent of  
32  P incorporation (top). The equal input 
of proteins in each lane was subsequently veriﬁ  ed by 
immunoblotting with the anti-HA antibody (bottom). 
(B) Inhibition of CK2 impairs phosphate incorporation 
into the dominant SDT repeats. The bands correspond-
ing to the labeled SDT fragments from A were excised 
from the gel and subjected to tryptic digestion. The result-
ing phosphopeptides were separated by electrophoresis 
followed by thin-layer chromatography and analyzed 
by phosphorimager. Note that the  
32  P incorporation 
into two prominent spots representing Ser 
299  /Thr 
301   (thin 
arrows) and Ser 
453  /Thr 
455   (bold arrows) is reduced to 
    50% in cells treated with CK2 inhibitor (CK2i). Dotted 
circles indicate spots whose labeling did not apprecia-
bly change after CK2 inhibition; the intensity of the  
32  P 
signal associated with these spots was taken as a base-
line to estimate the decrease in phosphate incorporation 
into the SDT repeats. Numbers indicate the charge of the 
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NBS1 and facilitate retention of the latter protein at the DSB-
modifi  ed chromatin. 
  Discussion 
  Our results elucidate the nature of one of the most proximal 
steps in the spatiotemporal evolution of DSB-modifi  ed chromatin. 
Specifi  cally, although availability of the MDC1 adaptor protein 
and the NBS1-FHA domain were known to regulate MRN chroma-
tin retention, the way these two factors communicate with each 
other   remained elusive. Our fi  ndings mechanistically explain this 
conundrum by identifying the conserved SDT repeats in the MDC1 
N terminus and by showing that their phosphorylation generates rec-
ognition sites for the NBS1-FHA domain. In addition, we identify 
CK2 as a candidate kinase that can phosphorylate the SDT repeats 
and show that the integrity of the SDT-associated phosphoacceptor 
residues is required for MRN retention at the sites of DNA damage. 
 At  fi  rst glance, it appears surprising that CK2, a ubiquitous 
and constitutively active kinase, regulates MDC1, a protein that 
functions almost exclusively in stochastic events triggered by 
genotoxic stress in which it operates strictly locally at the sites of 
chromosomal lesions. To comprehend this seemingly unusual 
cross talk, it is important to realize that MDC1 and NBS1 interact 
already in unstressed cells (  Goldberg et al., 2003  ;   Stewart et al., 
2003  ), and, as we show in this study, even this predamage interac-
tion is at least partly regulated by CK2. Based on this observation, 
the fi  rst obvious scenario that comes to mind is that as a result of 
cell line with stably depleted endogenous MDC1 (MDC1/shRNA; 
  Fig. 1 D  ). To test the suitability of this cellular model for the 
in vivo reconstitution experiments with heterologous MDC1 al-
leles, we fi  rst confi  rmed that the endogenous MDC1 in these 
cells was indeed down-regulated to the degree that prevented 
any cytologically discernible accumulation of NBS1 in the 
laser-generated DSB tracks (Fig. S3, available at http://www
.jcb.org/cgi/content/full/jcb.200708210/DC1). We then recon-
stituted this cell line with WT MDC1 or the phosphorylation-
defi  cient variants in which the Ser and Thr residues were mutated 
in two (4A) or in all six (12A) SDT repeats. All of these MDC1 
variants were generated in the context of full-length proteins, 
tagged with the HA epitope on the N terminus, and rendered 
insensitive to shRNA. Strikingly, although the WT and both 
phosphorylation-defi  cient forms of MDC1 avidly accumulated 
at the DSB-fl  anking chromatin, only the WT version was able 
to fully restore the retention of NBS1 in this compartment 
(  Fig. 7 B  , left). In contrast, cells expressing the MDC1-4A mutant 
retained only residual amounts of NBS1 at the DSB-modifi  ed 
chromatin ( Fig. 7 B , middle), and MDC1-12A completely failed 
to support any cytologically discernible accumulation of NBS1 
in these regions (  Fig. 7 B  , right). Importantly, these cell-based 
data closely matched the progressive loss of MDC1  –  NBS1 
interactions in the pull-down assay using the analogous MDC1 
phosphodefi  cient mutants (  Fig. 7 A  , compare lanes 1, 4, and 5). 
Together, these data suggest that the SDT-associated phosphor-
ylations trigger productive interaction between MDC1 and 
  Figure 6.       MDC1 associates with CK2 activity.   (A) MDC1 
N terminus copuriﬁ  es with CK2 activity. U2OS cells were 
transfected with HA-tagged MDC1 N terminus (p1100). 
After 24 h, the cells were left untreated or were subjected to 
10 Gy IR for 1 h. Cells were then lysed, and the MDC1 frag-
ment was immunoprecipitated with an anti-HA antibody and 
assayed for the ability to undergo autophosphorylation in an 
in vitro kinase assay. Where indicated, the kinase reaction 
was supplemented with 10   μ  M of the DMAT CK2 inhibitor 
(CK2i). After SDS-PAGE and transfer to nitrocellulose, the 
extent of MDC1 phosphorylation was analyzed by phos-
phorimager (top), and the equal input of MDC1 in each 
reaction was validated by immunoblotting with the anti-HA 
antibody (bottom). (B) Endogenous MDC1 associates with 
CK2 activity. Lysates from asynchronously growing U2OS or 
U2OS/shMDC1 cells were subjected to immunoprecipita-
tion with an MDC1-speciﬁ  c antibody and assayed for auto-
phosphorylation of endogenous MDC1 (top). The equal 
input of MDC1 in each reaction was validated by immuno-
blotting with the anti-MDC1 antibody (bottom). Where in-
dicated, 500 nM of the DMAT CK2 inhibitor (CK2i) was 
added to the kinase reaction.     JCB • VOLUME 181 • NUMBER 2 • 2008  222
et al., 2006  ), and a strong affi  nity trap on SDT-phosphorylated 
MDC1 would likely reduce MRN  ’  s fl  exibility and limit its acces-
sibility to nuclear compartments where it operates independently 
of MDC1. Indeed, kinetic analysis of NBS1 and MDC1 mobility 
in living cells revealed marked differences between these two 
proteins: although both NBS1 and MDC1 become retained at the 
DSB sites (a feature that determines formation of the cytologically 
its constitutive phosphorylation by CK2, MDC1 forms a stable 
holocomplex with MRN. In this model, the MRN focus formation 
simply refl  ects the propensity of MDC1 (as a fourth subunit of the 
MRN complex) to avidly interact with    -H2AX. Although  simple 
and attractive, several pieces of evidence suggest a more subtle way 
of regulation. First, MRN clearly has functions that do not require 
MDC1 (  Petrini and Stracker, 2003; Falck et al., 2005  ;   Jazayeri 
  Figure 7.       Disruption of the SDT phosphoacceptor sites impairs MDC1  –  NBS1 interaction and abrogates the retention of NBS1 at the DSB-modiﬁ  ed 
chromatin.   (A) Disruption of the SDT sites progressively inhibits MDC1  –  NBS1 interaction. U2OS cells were transfected with the HA-tagged MDC1 fragments 
spanning the intact N terminus (WT) and its derivatives where the indicated residues were substituted to alanines. The 4A fragment combines alanine 
substitutions of Ser299, Thr301, Ser453, and Thr455. In the 12A fragment, all of the 12 potential CK2 sites within the SDT region were mutated to 
alanines. After 24 h, lysates were prepared, immunoprecipitated with an anti-HA antibody, and analyzed by immunoblotting with the anti-NBS1 (top) 
and anti-HA (middle) antibodies. The immunoblotting of NBS1 from the whole cell extracts (bottom) validates an equal input of the lysate in each re-
action. WCE, whole cell extract. (B) Disruption of the SDT sites impairs the sustained retention of NBS1 at the sites of DNA damage. MDC1/shRNA cells 
were transiently transfected with expression plasmids coding for the WT or the SDT-deﬁ  cient 4A and 12A phosphorylation-deﬁ  cient mutants of MDC1, 
respectively (the same mutations as in A but generated in the context of siRNA-insensitive full-length HA-MDC1). After 24 h, cells were subjected to 
laser microirradiation to generate local DSBs. After an additional 1 h, the cells were ﬁ  xed and immunostained with antibodies to HA (to locate the 
DSB tracks) and to endogenous NBS1. The arrow indicates the residual amount of NBS1 retained in the DSB tracks in cells containing the MDC1-4A 
mutant. Bar, 10   μ  m.     223  MECHANISM OF NBS1 CHROMATIN RETENTION   •   MELANDER ET AL.
  Given these fi  ndings, the new data presented in this study, 
and similar results reached by Spycher et al. (see p. 227 of 
this issue), our current model describing the mechanism of 
MRN chromatin retention is as follows. In undamaged nuclei 
(  Fig. 8  , top), CK2 phosphorylates the SDT repeats of MDC1. 
Combined with the ability of the NBS1-FHA domain to recog-
nize phosphorylated SDTs, this allows constitutive yet highly 
dynamic MDC1  –  MRN interaction, which remains amenable to 
  discernible nuclear foci), the residence time of MDC1 at DSBs 
was nearly one order of magnitude longer compared with NBS1. 
As a result, although MDC1 becomes immobilized at the DSB-
fl  anking chromatin, NBS1 remains highly mobile, a feature com-
patible with its fl  exible exchange among distinct DSB-generated 
subcompartments (  Lukas et al., 2003, 2004a  ). Thus, the interac-
tion between MDC1 and NBS1 is dynamic, and these two factors 
do not appear to form a rigid holocomplex. 
  Figure 8.       A hypothetical model of the MDC1  –  MRN interac-
tion before and after DNA damage.   In undamaged cells, CK2 
targets the SDT-rich N terminus of MDC1. Phosphorylated 
SDTs are recognized by the FHA domain of NBS1 and allow 
dynamic interaction between MDC1 and the MRN complex 
(top). DSBs trigger the phosphorylation of H2AX (middle) fol-
lowed by its recognition by the MDC1-associated BRCT do-
mains (bottom). The resulting concentration of phosphorylated 
SDT repeated in the DSB-ﬂ  anking chromatin allows immediate 
recruitment of the MRN complex to this compartment. CK2 
(potentially together with another acidophilic kinase; indi-
cated by an asterisk) may then stimulate MRN retention at the 
DSB sites by phosphorylating additional SDT repeats. Alter-
natively, the SDT-associated phosphates might be stabilized 
by inhibition of a DSB-associated protein phosphatase (PPase). 
Both mechanisms are compatible with a dynamic MRN ex-
change between distinct DSB-generated subcompartments 
but prevent its dilution in the undamaged nucleoplasm. See 
Discussion for an additional explanation.     JCB • VOLUME 181 • NUMBER 2 • 2008  224
action in a cooperative fashion (  Fig. 7  ). Thus, it is possible that 
although only a subset of the SDT repeats generates the basal 
level of MDC1  –  MRN interaction in undamaged cells, the DSB-
associated MDC1 undergoes additional conformational changes 
in its N terminus that may allow phosphorylation of the entire 
SDT region and, thereby, locally increase the interaction plat-
form for NBS1 and indeed the entire MRN complex. Further 
studies will be required to discriminate among these scenarios. 
  Finally, we note that the role of CK2 in the DNA damage 
response is not unprecedented. The most striking parallel with 
our fi  ndings has been provided by   Loizou et al. (2004)  , who re-
ported that CK2 phosphorylates XRCC1, an adaptor protein 
involved in single-strand DNA break repair. This and the 
subsequent studies (  Clements et al., 2004  ;   Bekker-Jensen et al., 
2007  ;   Iles et al., 2007  ;   Kanno et al., 2007  ) showed that CK2-
mediated phosphorylation was required for the interaction of 
XRCC1 with other repair proteins such as polynucleotide ki-
nase, aprataxin, and XIP1 (the latter protein is also known as 
APLF and PALF, respectively). It is noteworthy that all of these 
proteins interacted with XRCC1 by their FHA domains, which 
is in striking analogy to the MDC1  –  NBS1 interaction described 
in this study. In addition, an exciting conceptual parallel between 
the CK2-XRCC1 and CK2-MDC1 interplay is provided by the 
fact that in both cases, CK2 targets large scaffold proteins that 
by themselves do not posses enzymatic activity but rather ap-
pear to integrate upstream signaling to organize other proteins at 
the vicinity of DNA lesions. The fact that CK2 targets different 
adaptor proteins engaged in distinct DNA repair processes 
(single-strand breaks and DSBs) suggests that phosphorylation 
of these molecular adaptors coevolved to increase the effi  ciency 
of the genome surveillance machinery. Although the recent genetic 
data strongly support the role of MRN chromatin retention for 
survival and genomic stability after DSB-generating insults (see 
Introduction), the CK2-mediated phosphorylation of XRCC1 
facilitates the single-stranded break repair by promoting the re-
cruitment of polynucleotide kinase and aprataxin and by pro-
tecting XIP1 from proteolytic degradation (  Clements et al., 
2004  ;   Loizou et al., 2004; Bekker-Jensen et al., 2007  ;   Iles et al., 
2007  ;   Kanno et al., 2007  ). When combined together, the previ-
ous fi  ndings and our new data support the emerging model that 
one important function of CK2 is to increase the effi  ciency of 
genome surveillance by targeting interaction matchmakers and 
thereby promoting the local concentration and/or stability of 
DNA damage regulators at sites of genetic lesions. 
  Materials and methods 
  Cell culture and gene transfer 
  The human osteosarcoma cell line U2OS (American Type Culture Col-
lection) was cultured in DME (Invitrogen) supplemented with 10% FCS, 
50 U/ml penicillin, and 50 mg/ml streptomycin. The U2OS stable derivative 
expressing the MDC1-targetting shRNA (U2OS/shRNA) was described 
previously (  Bekker-Jensen et al., 2006  ). All transfections were performed 
with FuGENE6 (Roche) according to the manufacturer  ’  s instructions, and 
cells were harvested after 24 h. 
  Plasmids 
  HA-tagged human MDC1 (pcDNA3-neo) was a gift from D. Stern (Yale 
University, New Haven, CT). HA-MDC1 fragments were generated by PCR 
and subcloned into a pcDNA4/TO (Invitrogen) plasmid. To the shorter 
further regulation and prevents sequestration of any of these 
factors in rigid aggregates. The latter feature could be crucial to 
allow the rapid recognition of DNA breaks by the MRN com-
plex, a process that is independent of MDC1 (see Introduction). 
After DSB generation (  Fig. 8  , bottom), the most proximal 
chromatin modifi  cation includes phosphorylation of the H2AX 
C terminus (    -H2AX). Although several DSB regulators contain 
phosphate interaction motifs and domains, the MDC1-BRCT 
domain appears to interact with     -H2AX with the highest af-
fi  nity (  Stucki et al., 2005  ), resulting in a rapid coating of the 
   -H2AX – primed chromatin by MDC1. At this point, the MDC1 
N terminus becomes important for the ensuing events on the 
DSB-fl  anking chromatin (  Fig. 8  , bottom). We propose that con-
stitutive phosphorylation of the SDT repeats (translated to a 
continuous generation of binding sites for the NBS1-FHA do-
main) is likely the most effi  cient means to avoid any delay in 
recruiting MRN to the modifi  ed chromatin rapidly evolving 
around the incipient DBS lesions. Indeed, integration of a con-
stitutive signal is consistent with the simultaneous recruitment 
of MDC1 and NBS1 to DSBs (  Lukas et al., 2004a  ;   Mailand 
et al., 2007  ) and suggests that in vertebrates, the SDT repeats of 
MDC1 coevolved with MRN to prime the latter for the fastest 
possible arrival at the sites of harmful chromosomal lesions. 
  Although our data and the complementary results ob-
tained by   Spycher et al. (2008)   strongly implicate CK2 in phos-
phorylating the MDC1 N terminus, we cannot exclude the 
possibility that other acidophilic kinases contribute to regulate 
the MDC1  –  NBS1 interaction. Most notably in this regard, we 
show in   Fig. 5   that chemical inhibition of CK2 reduced but did 
not abolish phosphorylation of the prominently phosphorylated 
SDT repeats (the maximum reduction of phosphate incorpora-
tion to these repeats was     50% compared with CK2-profi  cient 
cells). Unlike complete genetic disruption of the dominant SDT 
repeats (  Fig. 7 B  ), this degree of the SDT phosphorylation im-
pairment was not suffi  cient to prevent accumulation of NBS1 at 
the DSB sites (our unpublished data). 
  As alluded to in the preceding paragraphs of this section, 
this model poses an important conceptual question: how is con-
stitutive and ubiquitous phosphorylation of the MDC1 N termi-
nus transformed to a signal that locally and transiently enhances 
chromatin affi  nity for NBS1? The answer to this question is not 
trivial, but several scenarios come to mind ( Fig. 8 , bottom). First, 
it is possible that just the sheer increase in the local density of 
MDC1 (and the corresponding phosphates on the SDT repeats) 
may be suffi  cient to delay MRN at the DSBs to an extent that still 
allows its dynamic exchange between distinct DSB-generated 
subcompartments yet prevents its dilution in the undamaged 
parts of the nucleus. Second, although CK2 activity does not in-
crease after DNA damage, one can envisage that DSBs may lo-
cally regulate (inhibit) chromatin-associated phosphatases and 
thereby decrease the rate of SDT-phosphate turnover. In princi-
ple, this may also increase local density of phosphorylated SDT 
repeats and thereby stabilize the interaction between the MDC1 
N terminus and the NBS1-FHA domain. Third, an alternative 
(but not mutually exclusive) model is based on our observation 
that the MDC1 N terminus harbors a cluster of six SDT sites and 
that at least some of them contribute to the MDC1  –  NBS1 inter-225  MECHANISM OF NBS1 CHROMATIN RETENTION   •   MELANDER ET AL.
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and sheep polyclonal MDC1 antibodies were provided by S. Jackson (Gur-
don Institute, Cambridge, UK). The speciﬁ  c CK2 inhibitor InSolution DMAT 
was obtained from EMD and was used in concentrations speciﬁ  ed in the ﬁ  g-
ure legends. For immunoprecipitation, cells were lysed, and proteins were 
extracted in a high salt buffer (20 mM Tris, pH 7.5, 400 mM NaCl, 0.5% 
NP-40, 1 mM EDTA, and protease and phosphatase inhibitor mixture). After 
centrifugation of the lysates, an equal volume of the same buffer without 
NaCl was added to produce a ﬁ  nal NaCl concentration of 200 mM. Kinase 
assays and immunoblotting were performed as previously described (  Falck 
et al., 2005  ;   Mailand et al., 2006  ) except for the MDC1-associated kinase 
assay, in which no exogenous substrate was added. 
  In vivo labeling and phosphopeptide mapping 
  U2OS cells transfected with the indicated constructs were labeled for 4 h 
in phosphate-free DME with 20 mM Hepes, pH 7.2, and 5% dialyzed 
phosphate-free DME with 1 mCi/ml  
32  P (PBS43; GE Healthcare). Two-
dimensional phosphopeptide and phospho  –  amino acid mapping were per-
formed as described previously (  Blume-Jensen et al., 1995  ;   Hansen et al., 
1996  ). Tryptic phosphopeptides were separated on an electrophoresis sys-
tem (HTLE-7000; CBS Scientiﬁ  c Company, Inc.) at 2,000 V for 30 min at 
14  °  C. The second dimension chromatography was performed in isobutyric 
acid buffer for 14  –  16 h. Separated peptides were subjected to phosphor-
imager analysis (FLA-3000; Fuji). 
  CK2 kinase assay 
  1   μ  g of puriﬁ  ed GST or GST-MDC1 fragments was phosphorylated with 
100 U of recombinant CK2 kinase in the presence of 10   μ  Ci     -[ 
32  P]ATP for 
15 min at 37  °  C according to the manufacturer  ’  s instructions. The reaction 
was stopped by the addition of Laemmli sample buffer, and phosphory-
lated proteins were visualized by resolving the samples on SDS-PAGE fol-
lowed by autoradiography. 
  In vitro binding assay 
  2   μ  g of puriﬁ  ed GST-MDC1(181  –  480) fragments were left untreated or 
phosphorylated with recombinant CK2 (New England Biolabs, Inc.) for 30 min 
at 37  °  C in the presence of 1 mM ATP. The GST proteins were then bound 
to glutathione  –  Sepharose beads (GE Healthcare), and the beads were 
washed three times in EBC buffer (  Mailand and Difﬂ  ey, 2005  ). The beads 
were then incubated with in vitro  –  translated  
35  S-labeled Nbs1 for 2 h at 
4  °  C, washed four times with EBC buffer, resuspended in Laemmli sample 
buffer, and resolved by SDS-PAGE and autoradiography. 
  Laser microirradiation and microscopy 
  Induction of localized DSBs by microirradiation was performed as de-
scribed previously (  Lukas et al., 2003, 2004a; Bekker-Jensen et al., 2005, 
2006  ). In brief, U2OS cells and their derivatives were grown on glass cov-
erslips in the presence of 10   μ  M BrdU for 24 h and subsequently exposed 
to the pulsed UVA laser (     = 337 nm) along a narrow track spanning the 
entire nuclear diameter. After an additional hour, the cells were ﬁ  xed in 4% 
formaldehyde and subjected to immunostaining. Images were acquired with 
a confocal microscope (LSM 510; Carl Zeiss, Inc.) through a plan-Neoﬂ  uar 
40  ×   NA 1.3 oil immersion objective (Carl Zeiss, Inc.). For dual color imag-
ing, secondary antibodies coupled to AlexaFluor dyes with excitation wave-
lengths of 488 and 568 nm were used. Image acquisition and basic image 
processing were performed with LSM software (Carl Zeiss, Inc.). 
  Online supplemental material 
  Fig. S1 shows sequence alignment of the SDT-rich MDC1 regions in 
several vertebrate species. Fig. S2 provides in vivo evidence for the si-
multaneous phosphorylation of Ser and Thr residues within the indi-
vidual SDT repeats. Fig. S3 shows that constitutive down-regulation of 
MDC1 by shRNA impairs retention of NBS1 at the sites of DNA damage. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200708210/DC1. JCB • VOLUME 181 • NUMBER 2 • 2008  226
   Stucki ,   M. ,  and   S.P.    Jackson  .   2006  .   gammaH2AX and MDC1: anchoring the 
DNA-damage-response machinery to broken chromosomes.       DNA Repair 
(Amst.)   .    5 : 534  –  543 .    
   Stucki ,   M. ,   J.A.    Clapperton ,   D.    Mohammad ,   M.B.    Yaffe ,   S.J.    Smerdon , 
and   S.P.    Jackson .   2005 .   MDC1  directly  binds  phosphorylated  histone 
H2AX to regulate cellular responses to DNA double-strand breaks.       Cell   .  
 123 : 1213  –  1226 .    
   Spycher ,   C. ,   E.S.    Miller ,   K.    Townsend ,   L.    Pavic ,   N.A.    Morrice ,   P.    Janscak ,   G.S.  
 Stewart , and  M.   Stucki .  2008 .  Constitutive phosphorylation of MDC1 phys-
ically links the MRE11  – RAD50 – NBS1  complex  to  damaged  chromatin.  
  J. Cell Biol.     181 :   227      –  240 .  
   Tauchi ,   H. ,   J.    Kobayashi ,   K.    Morishima ,   S.    Matsuura ,  A.    Nakamura ,  T.    Shiraishi , 
 E.    Ito ,   D.    Masnada ,   D.    Delia ,  and   K.    Komatsu .   2001 .   The  forkhead-
  associated domain of NBS1 is essential for nuclear foci formation after 
irradiation but not essential for hRAD50[middle dot]hMRE11[middle 
dot]NBS1 complex DNA repair activity.       J. Biol. Chem.     276 : 12  –  15 .    
   Zhao ,   S. ,  W.    Renthal ,  and   E.Y.     Lee  .   2002  .   Functional analysis of FHA and BRCT 
domains of NBS1 in chromatin association and DNA damage responses.   
  Nucleic Acids Res.     30 : 4815  –  4822 .    
   Zhou ,   B.B. ,  and   S.J.    Elledge .   2000 .   The  DNA  damage  response:  putting  check-
points in perspective.       Nature   .    408 : 433  –  439 .             
of ATM activation after low doses of ionizing radiation.       Oncogene   .  
 23 : 3122  –  3127 .    
   Iles ,   N. ,   S.    Rulten ,   S.F.    El-Khamisy , and   K.W.     Caldecott .   2007 .  APLF  (C2orf13) 
is a novel human protein involved in the cellular response to chromo-
somal DNA strand breaks.       Mol. Cell. Biol.     27 : 3793  –  3803 .    
   Jazayeri ,  A. ,   J.    Falck ,   C.    Lukas ,   J.    Bartek ,   G.C.    Smith ,   J.    Lukas ,  and   S.P.    Jackson . 
  2006  .   ATM- and cell cycle-dependent regulation of ATR in response to 
DNA double-strand breaks.       Nat. Cell Biol.     8 : 37  –  45 .    
   Kanno ,   S. ,   H.    Kuzuoka ,   S.    Sasao ,   Z.    Hong ,   L.    Lan ,   S.    Nakajima ,  and   A.  
  Yasui  .   2007  .   A novel human AP endonuclease with conserved zinc-
fi  nger-like motifs involved in DNA strand break responses.       EMBO J.   
 26 : 2094  –  2103 .    
   Kastan ,   M.B. ,  and   J.    Bartek .   2004 .   Cell-cycle  checkpoints  and  cancer.     Nature   .  
 432 : 316  –  323 .    
   Kobayashi ,  J. ,  H.   Tauchi ,  S.   Sakamoto ,  A.   Nakamura ,  K.   Morishima ,  S.   Matsuura , 
 T.    Kobayashi ,   K.    Tamai ,   K.    Tanimoto ,  and   K.    Komatsu .   2002 .   NBS1  lo-
calizes to gamma-H2AX foci through interaction with the FHA/BRCT 
domain.     Curr. Biol.     12 : 1846  –  1851 .    
   Kobayashi ,   J. ,   A.    Antoccia ,   H.    Tauchi ,   S.    Matsuura ,  and   K.    Komatsu .   2004 . 
  NBS1 and its functional role in the DNA damage response.       DNA Repair 
(Amst.)   .    3 : 855  –  861 .    
   Lee ,   J.H. ,   B.    Xu ,   C.H.    Lee ,   J.Y.    Ahn ,   M.S.    Song ,   H.    Lee ,   C.E.    Canman ,   J.S.  
 Lee ,   M.B.    Kastan ,  and   D.S.    Lim .   2003 .   Distinct  functions  of  Nijmegen 
breakage syndrome in ataxia telangiectasia mutated-dependent responses 
to DNA damage.       Mol. Cancer Res.     1 : 674  –  681 .  
   Linding ,   R. ,   L.J.    Jensen ,   G.J.    Ostheimer ,   M.A.    van  Vugt ,   C.    Jorgensen ,   I.M.  
 Miron ,   F.    Diella ,   K.    Colwill ,   L.    Taylor ,   K.    Elder ,   et al  .   2007 .   Systematic 
discovery of in vivo phosphorylation networks.       Cell   .    129 : 1415  –  1426 .    
   Loizou ,   J.I. ,   S.F.    El-Khamisy ,   A.    Zlatanou ,   D.J.    Moore ,   D.W.    Chan ,   J.    Qin ,   S.  
 Sarno ,   F.    Meggio ,   L.A.    Pinna ,  and   K.W.    Caldecott .   2004 .   The  protein 
kinase CK2 facilitates repair of chromosomal DNA single-strand breaks.   
  Cell   .    117 : 17  –  28 .    
   Lou ,   Z. ,   K.    Minter-Dykhouse ,   S.    Franco ,   M.    Gostissa ,   M.A.    Rivera ,   A.    Celeste , 
 J.P.   Manis ,  J.   van Deursen ,  A.   Nussenzweig ,  T.T.   Paull ,  et al .  2006 .  MDC1 
maintains genomic stability by participating in the amplifi  cation of ATM-
dependent DNA damage signals.       Mol. Cell   .    21 : 187  –  200 .    
   Lukas ,   C. ,   J.    Falck ,   J.    Bartkova ,   J.    Bartek ,  and   J.    Lukas .   2003 .   Distinct  spatio-
temporal dynamics of mammalian checkpoint regulators induced by 
DNA damage.       Nat. Cell Biol.     5 : 255  –  260 .    
   Lukas ,   C. ,   F.    Melander ,   M.    Stucki ,   J.    Falck ,   S.    Bekker-Jensen ,   M.    Goldberg ,   Y.   
 Lerenthal ,   S.P.    Jackson ,   J.    Bartek ,  and   J.    Lukas .   2004a .   Mdc1  couples 
DNA double-strand break recognition by Nbs1 with its H2AX-dependent 
chromatin retention.       EMBO J.     23 : 2674  –  2683 .    
   Lukas ,   J. ,   C.    Lukas ,  and   J.    Bartek .   2004b .   Mammalian  cell  cycle  checkpoints: 
signalling pathways and their organization in space and time.    DNA Repair 
(Amst.)   .    3 : 997  –  1007 .    
   Lukas ,   C. ,   J.    Bartek ,  and   J.    Lukas .   2005 .   Imaging  of  protein  movement  induced  by 
chromosomal breakage: tiny   ‘  local  ’   lesions pose great   ‘ global ’   challenges.  
  Chromosoma   .    114 : 146  –  154 .    
   Mailand ,   N. ,  and   J.F.    Diffl  ey  .   2005  .   CDKs promote DNA replication origin 
licensing in human cells by protecting Cdc6 from APC/C-dependent 
proteolysis.     Cell   .    122 : 915  –  926 .    
   Mailand ,   N. ,   S.    Bekker-Jensen ,   J.    Bartek ,  and   J.    Lukas .   2006 .   Destruction  of 
Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recov-
ery from genotoxic stress.       Mol. Cell   .    23 : 307  –  318 .    
   Mailand ,   N. ,   S.    Bekker-Jensen ,   H.    Faustrup ,   F.    Melander ,   J.    Bartek ,   C.    Lukas , 
and   J.    Lukas .   2007 .   RNF8  ubiquitylates  histones  at  DNA  double-strand 
breaks and promotes assembly of repair proteins.       Cell   .    131 : 887  –  900 .    
   Nyberg ,   K.A. ,   R.J.    Michelson ,   C.W.    Putnam ,  and   T.A.    Weinert .   2002 .   Toward 
maintaining the genome: DNA damage and replication checkpoints.   
  Annu. Rev. Genet.     36 : 617  –  656 .    
   Olsen ,   J.V. ,   B.    Blagoev ,   F.    Gnad ,   B.    Macek ,   C.    Kumar ,   P.     Mortensen ,  and   M.  
 Mann .   2006 .   Global,  in  vivo,  and  site-specifi  c phosphorylation dynamics 
in signaling networks.       Cell   .    127 : 635  –  648 .    
   Petrini ,   J.H. ,  and   T.H.    Stracker .   2003 .   The  cellular  response  to  DNA  double-strand 
breaks: defi  ning the sensors and mediators.       Trends Cell Biol.     13 : 458  –  462 .    
   Shiloh ,  Y.    2003 .  ATM  and  related  protein  kinases:  safeguarding  genome  integrity.  
  Nat. Rev. Cancer   .    3 : 155  –  168 .    
   Stewart ,   G.S. ,   B.    Wang ,   C.R.    Bignell ,   A.M.    Taylor ,  and   S.J.    Elledge .   2003 . 
  MDC1 is a mediator of the mammalian DNA damage checkpoint.       Nature   .  
 421 : 961  –  966 .    
   Stracker ,   T.H. ,   J.W.    Theunissen ,   M.    Morales ,  and   J.H.    Petrini .   2004 .   The  Mre11 
complex and the metabolism of chromosome breaks: the importance of com-
municating and holding things together.       DNA Repair (Amst.)   .    3 : 845  –  854 .    
   Stracker ,   T.H. ,   M.    Morales ,   S.S.    Couto ,   H.    Hussein ,  and   J.H.    Petrini .   2007 .   The 
carboxy terminus of NBS1 is required for induction of apoptosis by the 
MRE11 complex.       Nature   .    447 : 218  –  221 .    